LINC00511 and urinary bladder carcinoma: Subsequently, high expression of LINC00511 was further confirmed in lung adenocarcinoma [14], lung squamous cell carcinoma [14], breast cancer [21], pancreatic cancer [22], bladder cancer [23], osteosarcoma [24], and tongue squamous cell carcinoma [25].